618 related articles for article (PubMed ID: 8719696)
1. The dyschromatopsia of optic neuritis: a descriptive analysis of data from the optic neuritis treatment trial.
Katz B
Trans Am Ophthalmol Soc; 1995; 93():685-708. PubMed ID: 8719696
[TBL] [Abstract][Full Text] [Related]
2. Color vision defect type and spatial vision in the optic neuritis treatment trial.
Schneck ME; Haegerstrom-Portnoy G
Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2278-89. PubMed ID: 9344351
[TBL] [Abstract][Full Text] [Related]
3. The dyschromatopsia of optic neuritis is determined in part by the foveal/perifoveal distribution of visual field damage.
Silverman SE; Hart WM; Gordon MO; Kilo C
Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1895-902. PubMed ID: 2211035
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of color vision in acute unilateral optic neuritis using a web-based color vision test].
Kuchenbecker J; Blum M; Paul F
Ophthalmologe; 2016 Mar; 113(3):223-9. PubMed ID: 26224172
[TBL] [Abstract][Full Text] [Related]
5. Impairment of acquired color vision in multiple sclerosis: an early diagnostic sign linked to the greatness of disease.
Piro A; Tagarelli A; Nicoletti G; Scannapieco S; Polidoro S; Valentino P; Quattrone A
Int Ophthalmol; 2019 Mar; 39(3):671-676. PubMed ID: 29392642
[TBL] [Abstract][Full Text] [Related]
6. The Farnsworth-Munsell 100 hue test in the first episode of demyelinating optic neuritis.
Ménage MJ; Papakostopoulos D; Dean Hart JC; Papakostopoulos S; Gogolitsyn Y
Br J Ophthalmol; 1993 Feb; 77(2):68-74. PubMed ID: 8435421
[TBL] [Abstract][Full Text] [Related]
7. A new colour vision test for clinical use.
Kon CH; De Alwis D
Eye (Lond); 1996; 10 ( Pt 1)():65-74. PubMed ID: 8763306
[TBL] [Abstract][Full Text] [Related]
8. Color vision and color pattern visual evoked cortical potentials in a patient with acquired cerebral dyschromatopsia.
Adachi-Usami E; Tsukamoto M; Shimada Y
Doc Ophthalmol; 1995; 90(3):259-69. PubMed ID: 8846734
[TBL] [Abstract][Full Text] [Related]
9. Dyschromatopsia in Multiple Sclerosis Patients: A Marker of Subclinical Involvement?
Felgueiras H; Parra J; Cruz S; Pereira P; Santos AF; Rua A; Meira D; Fonseca P; Pedrosa C; Cardoso JN; Almeida C; Araújo M; Santos E
J Neuroophthalmol; 2016 Sep; 36(3):275-9. PubMed ID: 27261948
[TBL] [Abstract][Full Text] [Related]
10. [Tests for acquired dyschromatopsia. Significance of color perception test in fundal diseases].
Ota Y
Ganka; 1966 Sep; 8(9):797-803. PubMed ID: 5298600
[No Abstract] [Full Text] [Related]
11. Chromatic discrimination losses in multiple sclerosis patients with and without optic neuritis using the Cambridge Colour Test.
Moura AL; Teixeira RA; Oiwa NN; Costa MF; Feitosa-Santana C; Callegaro D; Hamer RD; Ventura DF
Vis Neurosci; 2008; 25(3):463-8. PubMed ID: 18598419
[TBL] [Abstract][Full Text] [Related]
12. Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group.
Arch Ophthalmol; 1997 Dec; 115(12):1545-52. PubMed ID: 9400788
[TBL] [Abstract][Full Text] [Related]
13. Chromatic and luminance losses with multiple sclerosis and optic neuritis measured using dynamic random luminance contrast noise.
Flanagan P; Zele AJ
Ophthalmic Physiol Opt; 2004 May; 24(3):225-33. PubMed ID: 15130171
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of optic neuritis in Hong Kong population: 10-year review.
Choy BNK; Ng ALK; Lai JSM
Int Ophthalmol; 2018 Apr; 38(2):557-564. PubMed ID: 28289949
[TBL] [Abstract][Full Text] [Related]
15. Fellow eye abnormalities in acute unilateral optic neuritis. Experience of the optic neuritis treatment trial.
Beck RW; Kupersmith MJ; Cleary PA; Katz B
Ophthalmology; 1993 May; 100(5):691-7; discussion 697-8. PubMed ID: 8493012
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal follow-up of vision in a neuromyelitis optica cohort.
Bouyon M; Collongues N; Zéphir H; Ballonzoli L; Jeanjean L; Lebrun C; Chanson J; Blanc F; Fleury M; Outteryck O; Defoort S; Labauge P; Vermersch P; Speeg C; De Seze J
Mult Scler; 2013 Sep; 19(10):1320-2. PubMed ID: 23413296
[TBL] [Abstract][Full Text] [Related]
17. Incidence of dyschromatopsy in glaucoma.
Bayer L; Funk J; Töteberg-Harms M
Int Ophthalmol; 2020 Mar; 40(3):597-605. PubMed ID: 31705359
[TBL] [Abstract][Full Text] [Related]
18. Association of Individual-Level Factors With Visual Outcomes in Optic Neuritis: Secondary Analysis of a Randomized Clinical Trial.
De Lott LB; Burke JF; Andrews CA; Costello F; Cornblath WT; Trobe JD; Lee PP; Kerber KA
JAMA Netw Open; 2020 May; 3(5):e204339. PubMed ID: 32379333
[TBL] [Abstract][Full Text] [Related]
19. Tokyo Medical College Test in acquired dyschromatopsia.
Pinckers A
Ophthalmologica; 1980; 181(1):7-12. PubMed ID: 6970911
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and outcome of childhood optic neuritis at Queen Sirikit National Institute of Child Health.
Sri-udomkajorn S; Pongwatcharaporn K
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S189-94. PubMed ID: 22043775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
